The Efficacy and Safety of Rituximab in Patients with Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease: Case Series

Idiopathic inflammatory myopathy (IIM)-associated interstitial lung disease (ILD) is often rapidly progressive with a poor prognosis; however, no standard therapeutic regimen has been identified. This study aimed to investigate the efficacy and safety of rituximab in IIM-ILD patients. Five patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Youngeun, Yoon, Hee-Young, Kim, Hyun-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219281/
https://www.ncbi.nlm.nih.gov/pubmed/37240516
http://dx.doi.org/10.3390/jcm12103406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219281/
https://www.ncbi.nlm.nih.gov/pubmed/37240516
http://dx.doi.org/10.3390/jcm12103406

Ejemplares similares